Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways

Lung cancer is the leading cause of cancer-associated death worldwide and exhibits intrinsic and acquired therapeutic resistance to cisplatin (CIS). The present study investigated the role of mTOR signaling and other signaling pathways after metformin (MET) treatment in control and cisplatin-resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Morelli, Ana Paula, Tortelli, Tharcísio Citrângulo, Pavan, Isadora Carolina Betim, Silva, Fernando Riback, Granato, Daniela Campos, Peruca, Guilherme Francisco, Pauletti, Bianca Alves, Domingues, Romênia Ramos, Bezerra, Rosangela Maria Neves, De Moura, Leandro Pereira, Leme, Adriana Franco Paes, Chammas, Roger, Simabuco, Fernando Moreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041480/
https://www.ncbi.nlm.nih.gov/pubmed/33846781
http://dx.doi.org/10.3892/ijo.2021.5208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041480/
https://www.ncbi.nlm.nih.gov/pubmed/33846781
http://dx.doi.org/10.3892/ijo.2021.5208

Ejemplares similares